Obesity III: Obesogen assays: Limitations, strengths, and new directions - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Biochemical Pharmacology Année : 2022

Obesity III: Obesogen assays: Limitations, strengths, and new directions

Christopher D Kassotis
  • Fonction : Auteur
  • PersonId : 1134563
Robert Barouki

Résumé

There is increasing evidence of a role for environmental contaminants in disrupting metabolic health in both humans and animals. Despite a growing need for well-understood models for evaluating adipogenic and potential obesogenic contaminants, there has been a reliance on decades-old in vitro models that have not been appropriately managed by cell line providers. There has been a quick rise in available in vitro models in the last ten years, including commercial availability of human mesenchymal stem cell and preadipocyte models; these models require more comprehensive validation but demonstrate real promise in improved translation to human metabolic health. There is also progress in developing three-dimensional and co-culture techniques that allow for the interrogation of a more physiologically relevant state. While diverse rodent models exist for evaluating putative obesogenic and/or adipogenic chemicals in a physiologically relevant context, increasing capabilities have been identified for alternative model organisms such as Drosophila, C. elegans, zebrafish, and medaka in metabolic health testing. These models have several appreciable advantages, including most notably their size, rapid development, large brood sizes, and ease of high-resolution lipid accumulation imaging throughout the organisms. They are anticipated to expand the capabilities of metabolic health research, particularly when coupled with emerging obesogen evaluation techniques as described herein.
Fichier principal
Vignette du fichier
Kassotis et al -2022-Obesity III Obesogen Assays.pdf (1.31 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03669590 , version 1 (23-09-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Christopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, Dominique Lagadic-Gossmann, Helene Le Mentec, et al.. Obesity III: Obesogen assays: Limitations, strengths, and new directions. Biochemical Pharmacology, 2022, 199, pp.115014. ⟨10.1016/j.bcp.2022.115014⟩. ⟨hal-03669590⟩
85 Consultations
158 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More